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Abstract Glucose concentrations of normal human airway
surface liquid are ~12.5 times lower than blood glucose
concentrations indicating that glucose uptake by epithelial
cells may play a role in maintaining lung glucose
homeostasis. We have therefore investigated potential
glucose uptake mechanisms in non-polarised and polarised
H441 human airway epithelial cells and bronchial biopsies.
We detected mRNA and protein for glucose transporter type
2 (GLUT2) and glucose transporter type 4 (GLUT4) in
non-polarised cells but GLUT4 was not detected in the
plasma membrane. In polarised cells, GLUT2 protein was
detected in both apical and basolateral membranes. Fur-
thermore, GLUT2 protein was localised to epithelial cells
of human bronchial mucosa biopsies. In non-polarised
H441 cells, uptake of D-glucose and deoxyglucose was
similar. Uptake of both was inhibited by phloretin indicat-
ing that glucose uptake was via GLUT-mediated transport.
Phloretin-sensitive transport remained the predominant
route for glucose uptake across apical and basolateral
membranes of polarised cells and was maximal at 5–
10 mM glucose. We could not conclusively demonstrate
sodium/glucose transporter-mediated transport in non-
polarised or polarised cells. Our study provides the first
evidence that glucose transport in human airway epithelial
cells in vitro and in vivo utilises GLUT2 transporters. We
speculate that these transporters could contribute to glucose
uptake/homeostasis in the human airway.
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Introduction
The luminal surface of the lung from nose to alveoli is lined
with a thin layer of fluid (airway surface liquid, ASL). We
estimate that glucose concentrations of normal human ASL
are 12.5 times lower than blood glucose concentrations [3],
similar to observations made in sheep and rat lungs [4, 39].
Low ASL glucose concentrations could contribute to
pulmonary defence against infection. Patients admitted to
intensive care with high ASL glucose concentrations are
more likely to develop lung infections, particularly with
methicillin-resistant Staphylococcus aureus (MRSA), than
those with low ASL glucose concentrations [34]. Mainte-
nance of low ASL glucose concentrations could form part
of a therapeutic strategy against respiratory infection, but
mechanisms underlying airway glucose uptake and ASL
glucose homeostasis are not fully understood.
ASL glucose concentrations increase as blood glucose is
raised and falls as blood glucose falls, but against the
transepithelial glucose gradient [3, 42]. This indicates that
glucose is cleared from ASL by glucose transporters in the
apical membrane of airway epithelial cells.
Glucose transporters can be divided into two groups.
The facilitative glucose transporters (GLUTs) transport
glucose into or out of the cell dependent on the glucose
gradient. Under normal conditions, GLUTs transport
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glucose into the cell down its concentration gradient which
is maintained by the rapid metabolism of glucose to
glucose-6-phosphate as soon as it enters the cell. The
sodium/glucose co-transporters (SGLT) require the co-
transport of Na+ and can utilise the transmembrane Na+
gradient to drive concentrative glucose uptake [45]. Animal
studies indicate that both transporter types are functionally
expressed in respiratory epithelium. SGLT-1 mRNA, but
not protein, was detected in rat and mouse whole lung
tissue and rat alveolar type II pneumocytes [18, 10].
Glucose removal from the lumen of fetal sheep and adult
rat lungs was inhibited by the SGLT inhibitor phlorizin [4,
38]. Phlorizin also caused a small depolarisation of bovine
and sheep tracheal epithelium, implying SGLT activity [40,
21]. GLUT1, GLUT2, GLUT4 and GLUT5 mRNA were
detected in rat type II alveolar cells [28]. We have also
shown that GLUT1 and GLUT2 mRNA were present in
human airway by PCR [41]. Glucose uptake by isolated
guinea pig type II pneumocytes was inhibited by the
GLUT-blocker phloretin [25]. However, glucose absorption
from fluid filled adult rat lungs was not phloretin-sensitive
[39], indicating that GLUT transport did not contribute to
apical glucose absorption in the distal lung of this species.
The aim of this study was to elucidate mechanisms of
glucose transport by human airway epithelial cells. We used
immortalised cultured H441 cells, which derive from a
papillary adenocarcinoma of the bronchiolar epithelium.
When cultured at air interface, these cells form an
absorptive epithelial monolayer, exhibit vectorial ion
transport processes and have similar morphological and
phenotypic characteristics to human bronchiolar epithelium
[17]. Observations were then confirmed in intact human
bronchial epithelium obtained at bronchoscopy.
Materials and methods
Cell culture
H441 cells obtained from the American Type Culture
Collection (ATCC, Manassas, VA, USA) were cultured in
RPMI-1640 media + 10% foetal bovine serum (FBS)
(Invitrogen, UK); glucose (10 mM); L-glutamine (2 mM);
sodium pyruvate (1 mM); insulin (10 μg/ml); transferrin
(5 μg/ml); sodium selenite (7 ng/ml); penicillin (100 U/ml);
and streptomycin (100 μg/ml). Non-polarised cells were
grown in 12-well tissue culture plates. Polarised mono-
layers were produced by culturing cells for 7 days on
permeable 4-µm pore polyester membrane supports (Trans-
wells, Corning, MA, USA). The basolateral membrane was
exposed to RPMI media [4% charcoal stripped serum;
glucose (10 mM); dexamethasone (200 μM); 3,3′-5-
Triiodothyronine (10 nM); L-glutamine (2 mM); sodium
pyruvate (1 mM); insulin (10 μg/ml); transferrin (5 μg/ml);
sodium selenite (7 ng/ml); penicillin (100 U/ml); and
streptomycin (100 μg/ml)] and the apical membrane was
at air interface. The day before the experiment, cells were
washed with glucose-free RPMI media and incubated in
medium with the required glucose concentration.
Glucose uptake experiments
Cultured cells were washed twice with glucose-free
transport medium [15 mM HEPES buffer (pH 7.6),
135 mM NaCl, 5 mM KCl, 1.8 mM CaCl2 and 0.8 mM
MgCl2] to remove culture medium, then incubated for
15 min at room temperature in the same solution to deplete
the cells of intracellular glucose (± inhibitors).
Uptake experiments were performed as described previ-
ously [32]. In non-polarised cells, the experiment was
initiated by replacing the medium with 0.5 ml transport
medium containing 1.0 μCi of radiolabelled glucose or
glucose analogue plus 10 mM of non-radiolabelled equiva-
lent glucose or glucose analogue (tracer mix), followed by
incubation at room temperature for 10 min. Preliminary
experiments indicated that uptake was linear between 0 and
10 min (data not shown). Uptake was terminated by adding
2 ml ice-cold stop solution [15 mM HEPES buffer (pH 7.6);
135 mM choline Cl; 5 mM KCl; 0.8 mM MgSO4; 1.8 mM
CaCl2 and 0.2 mM HgCl2]. The cells were then rinsed twice
with 2 ml stop solution and lysed in 0.5 ml of 10 mM Tris–
HCl (pH 8.0) with 0.2% SDS. Lysed samples were added to
2 ml scintillation cocktail and radio-active emissions
determined using a scintillation counter to quantify glucose
uptake. Each uptake experiment was performed three times
(n=3) unless otherwise stated. The same basic protocol was
used for all experiments with the following modifications: In
polarised monolayers, the radioactive tracer mix was added
either to the basolateral or apical side of the monolayer.
Most glucose uptake studies were carried out using [3H]-
D-glucose, which is transported by all glucose transporters.
Radiolabelled glucose analogues [3H]-deoxyglucose (DOG)
(Sigma, UK) and [14C]-α-methyl-D-glucopyranoside
(AMG) (Amersham, UK) were used to study GLUT- and
SGLT-mediated glucose transport, respectively.
The effect of different glucose concentrations on glucose
transport was determined by culturing cells at different
glucose concentrations (1, 5, 10, and 15 mM) the day before
the experiment. Cells from the same passage were used for
all uptake experiments at different glucose concentrations to
avoid discrepancies in results.
Several inhibitors were used to block glucose transport.
Phlorizin (500 μM dissolved in ethanol) is a high affinity
inhibitor of Na+–D-glucose co-transport via SGLT in whole
tissue [13, 14]. Phloretin (1 mM dissolved in ethanol) and
cytochalasin B (10 μM) inhibit glucose transport mediated
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by GLUTs in whole tissue [24]. Ouabain (1 mM dissolved
in ethanol), which inhibits Na+K+ATPase activity, and Na+
substitution with choline were also used in some experi-
ments to determine if glucose transport was coupled to the
Na+ gradient (SGLT-mediated). The amount of ethanol used
to dissolve inhibitors (5 μl/well, 1% of total volume) was
added to cells in control groups (vehicle control, 1% of total
volume). Where inhibitors were used in experiments, they
were added as soon as cells were transferred from culture to
transport medium.
Reverse transcriptase polymerase chain reaction
Total RNAwas isolated from H441 cells using the RNeasy kit
(Qiagen). cDNA was generated using reverse transcriptase
(Superscript II, Invitrogen, Carlsbad, CA, USA). Reverse
transcriptase polymerase chain reaction (RT-PCR) was per-
formed using primer sequences derived from regions within
GLUT1–GLUT4 and SGLT1 coding regions in a PCR
reaction mix [1.5 mM MgCl2, 250 nM of each primer and
0.2 U of AGS gold Taq polymerase (Hybaid, Ashford,
Middx, UK)]. PCR products were fractionated on 1.2%
agarose gels and visualized by ethidium bromide staining
and UV fluorescence. The following primer pairs were used
in the reactions. GLUT1 sense: TCCACGGAGCATCTTC
GAGA; GLUT1 anti-sense: ATACTGGAAGCACATGCCC
(cycling protocol of 94°C for 1 min, 56°C for 1 min and 72°
C for 90 s for 40 cycles); GLUT2 sense: CACT
GATGGCTGCATGTGGC; GLUT2 anti-sense: ATGTGAA
CAGGGTAAAGGCC (cycling protocol of 94°C for 1 min,
56°C for 1 min and 72°C for 90 s for 40 cycles); GLUT2
nested sense: CTACTCAACCAGCATTTTTC; GLUT2
nested anti-sense: AACACATAAGGTCCACAGAA (cy-
cling protocol of 94°C for 1 min, 52°C for 1 min and
72°C for 90 s for 40 cycles); GLUT3 sense: AAGGAT
AACTATAATGG; GLUT3 anti-sense: GGTCTCCTTAG
CAGGCT (cycling protocol of 95°C for 45 s, 46°C for 30 s
and 72°C for 45 s for 37 cycles); GLUT4 sense: GCCATTGT
TATCGGCATTCT; GLUT4 anti-sense: GAGCTGGAG
CAGGGACAGT (cycling protocol of 94°C for 1 min, 51°C
for 1 min and 72°C for 1 min for 35 cycles). Primers
amplifying a region of β-actin were used as an internal
control. β-actin sense: CGGGACCTGACTGACTACC; β-
actin anti-sense: TGAAGGTAGTTTCGTGGATGC (cycling
protocol of 94°C for 3 min, 53°C for 1 min and 72°C for 1 min
for 35 cycles). Cycle curves for all sets of PCR primers were
performed. The number of cycles performed for each primer
set was in the linear range of the curve.
Protein preparation
Total cell protein was prepared from cells scraped from
flasks and homogenised in tissue lysis buffer [100 mM Tris
pH, 6.8, 1 mM EDTA pH 8.0, 1% NP-40, 10% v/v glycerol
and 10 ml/l protease inhibitor cocktail] followed by centrifu-
gation (5 min, 250×g) to remove nuclei. Plasma membranes
were isolated as previously described [6]. Briefly, cells were
grown in six T75 flasks, lysed and the membranes separated
from the intracellular fraction by centrifugation (60,000×g,
4°C, 30 min). Membrane and intracellular fractions were
suspended in lysis buffer as above.
Membrane protein biotinylation
Apical or basolateral membrane proteins were biotinylated as
previously described [43]. Briefly, after 6 days at air
interface, polarised cells were washed with ice-cold PBS.
Sulfo-NHS-biotin (0.5 mg/ml) was applied to the apical or
basolateral membrane. Cells were then lysed, proteins
solubilised and incubated overnight with streptavidin agarose
beads. The following day, biotinylated proteins bound to
beads were separated from non-biotinylated proteins by
centrifugation and samples prepared for immunoblotting.
Western blotting
Membrane protein fractions (50 μg) were separated on 4–
12% Bis-Tris acrylamide gels, transferred to polyvinylidine
difluoride membranes and incubated overnight at 4oC with
anti GLUT1–GLUT4 affinity-purified antisera (1:200;
Alpha Diagnostic, San Antonio, TX and Millipore, UK)
or mouse monoclonal anti β-actin (1:500, AbCam, Cam-
bridge, UK) or mouse monoclonal anti α1-Na+K+ATPase
(1:1,000, Developmental Studies Hybridoma Bank, Uni-
versity of Iowa, USA). Blots were washed three times in
PBS + 0.01% TWEEN 20 then incubated with either
biotinylated donkey anti-rabbit IgG or rabbit anti-mouse
secondary antiserum (1:200) (GE Healthcare, UK) followed
by streptavidin horseradish peroxidase (HRP) conjugate
(1:200) (GE Healthcare, UK) for 1 h each at room
temperature. Immunostained proteins were visualised using
enhanced chemiluminescence (ECL) western blot analysis
system (NEN Life Science Products, Boston, MA; Western
lightning, PerkinElmer, Norwalk, CT, USA) and exposure
to X-ray film. All western blots were repeated at least twice.
Blots of protein from cells grown at different glucose
concentrations were processed simultaneously to allow visual
comparisons to be made. Binding specificity of GLUT2
antibodies was confirmed in a repeat experiment where
membranes were pre-incubated with antigenic peptides.
Measurement of short circuit current (Isc)
Polarised monolayers were mounted in Ussing chambers
with both apical and basolateral surfaces bathed in a
physiological salt solution [117 mM NaCl; 25 mM
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NaHCO3; 4.7 mM KCl; 1.2 mM MgSO4; 1.2 mM KH2PO4;
2.5 mM CaCl2; 11 mM D-glucose, equilibrated with 5%
CO2 to pH 7.3–7.4]. The solution was maintained at 37°C,
bubbled with premixed gas [21% O2+5% CO2] and
circulated continuously throughout the experiment. Mono-
layers were maintained under open circuit conditions whilst
transepithelial potential difference (Vt) and resistance (Rt)
were monitored and observed to reach a stable level. The
cells were then short circuited by clamping Vt at 0 mV
using a DVC-4000 voltage/current clamp. The current
required to maintain this condition (Isc) was measured and
recorded using a PowerLab computer interface. Every 30 s
throughout each experiment, the preparations were returned
to open circuit conditions for 3 s so that the spontaneous Vt
could be measured and Rt could be calculated as previously
described [44].
The contribution of SGLT and epithelial sodium chan-
nels (ENaC) to Isc were measured by adding 500 μM
phlorizin or vehicle control to the apical or basolateral
solution and 10 μM amiloride to the apical bath, respec-
tively. Ion transport across these cells is dependent on
Na+K+ATPase activity. Thus, ouabain (1 mM) was added to
the basolateral compartment to calculate values for total Isc.
Immunofluorescence staining of human bronchial
epithelium
Endobronchial biopsies were obtained at bronchoscopy
from two patients with chronic obstructive pulmonary
disease and a patient with no airway disease participating
in a study approved by King’s College Research Ethics
Committee. Participants gave written informed consent for
inclusion in the study. Biopsies were frozen immediately at
optimal cutting temperature and stored at −80°C. Cryostat
sections of 7 μm were mounted on polysine-coated slides.
Sections were blocked with 10% chicken serum (ISL) in
0.1% Triton X-100-PBS. Sections were incubated with
rabbit polyclonal antibodies raised against the human liver
GLUT2 transporter (1:100 dilution in 0.1%Triton-PBS;
Chemicon, Hampshire, UK) at room temperature for 1 h.
After washing 3×10 min in PBS, sections were incubated
in FITC-conjugated goat anti-rabbit IgG 1:100 diluted in
0.1% Triton-PBS for 30 min at room temperature. Slides
were washed three times for 10 min in PBS, sections were
then counterstained with 4′,6-diamidino-2-phenyindole
(DAPI; 1:1,000 diluted in 0.1% Triton-PBS) to localise
cell nuclei. Sections were also incubated with FITC-
conjugated goat anti-rabbit IgG alone or GLUT2 antiserum
pre-absorbed with a 10-fold excess of antigenic peptide for
20 min. Images were observed with a fluorescence
microscope Zeiss with Axioplan 2 analysis system using
the Axiovision 4.5 software. Cell fluorescence was
recorded by excitation at 450–490 nm.
Chemicals and reagents
All chemicals and reagents were obtained from Sigma,
Poole, UK unless otherwise stated.
Values are reported as mean±SEM. Statistical analysis
was performed using paired Student’s t tests or one-way
ANOVA tests (where appropriate). P values of <0.05 were
considered statistically significant.
Results
Glucose uptake by non-polarised cells
Non-polarised cells bathed in 10 mM glucose without
inhibitors (control) took up 39.7±7.3 nmol labelled D-
glucose/mg protein. In the presence of phloretin, D-glucose
uptake was lower at 5.6±1.7 nmol/mg protein (p<0.01, n=6)
compared to control. D-Glucose uptake was not significantly
different from control in the presence of phlorizin or ouabain
(Fig. 1a).
In the absence of inhibitors, AMG uptake was lower than
D-glucose uptake at 0.62±0.22 nmol/mg protein (Fig. 1b).
None of the inhibitors significantly reduced AMG uptake.
DOG uptake in the absence of inhibitors (control, 44.4±
5.1 nmol/mg protein) was similar to D-glucose uptake
(Fig. 1c). DOG uptake was significantly lower than in
control in the presence of either phloretin (9.7±1.5 nmol/mg
protein) or cytochalasin B (3.5±0.7 nmol/mg protein) (p<
0.05, n=3, respectively), but not significantly lower in the
presence of ouabain, phlorizin or choline. Overall, these
results demonstrate that non-polarised H441 epithelial cells
predominantly take up glucose through GLUT transporters.
Effect of glucose concentration on glucose uptake
by non-polarised cells
Glucose uptake by non-polarised cells was measured follow-
ing incubation in culture medium containing a range of
physiological glucose concentrations: 1 mM (hypoglycae-
mic); 5 mM (normoglycaemic); 10 mM (mildly hyper-
glycaemic) and 15 mM (hyperglycaemic). Glucose uptake in
the absence of inhibitors (control) was lowest at 1 mMglucose
(18.4±0.4 nmol/mg protein), increased at 5 mM (25.9±
0.3 nmol/mg protein) and was greatest at 10 mM glucose
(39.7±7.3 nmol/mg protein) and at 15 mM glucose (34.0±
2.7 nmol/mg protein) (n=3) (Figs. 1a and 2a–c).
The GLUT inhibitor phloretin significantly reduced
glucose uptake at all glucose concentrations (1 mM to
1.2±0.1; 5 mM to 3.6±0.5 and 15 mM to 4.1±0.2 nmol/mg
protein, p<0.01, n=6, respectively) compared to control
studies without inhibitors. Values for 10 mM glucose are
given above. Phlorizin did not significantly affect glucose
uptake at any glucose concentration (Figs. 1a and 2a–c).
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Fig. 1 Glucose uptake in non-
polarised H441 cells. Effect of
pre-incubation with vehicle
(control), 500 μM phlorizin
(PZ), 1 mM phloretin (PT),
1 mM ouabain (OU), 10 μM
cytochalasin B (Cyt B) or Na+
replacement with choline (cho-
line) on the uptake of 10 mM
glucose (traced by [3H]-glucose)
(a), [14C]-α-methyl-D-glucopyr-
anoside (AMG) (b) or [3H]-
deoxyglucose (DOG) (c).
Uptake experiments were per-
formed at 37°C. Data are shown
as mean±SEM. *p<0.05, sig-
nificantly different from control.
**p<0.01, significantly different
from control
Fig. 2 Uptake of glucose
(traced by [3H]-glucose) by
non-polarised H441 cells incu-
bated in culture medium con-
taining 1 mM (a), 5 mM (b) or
15 mM (c) glucose. Cells were
pre-incubated with vehicle
(control), 500 μM phlorizin
(PZ) or 1 mM phloretin (PT)
before measurement of glucose
uptake. Uptake experiments
were performed at 37°C. Data
are presented as mean±SEM.
**p<0.01, significantly different
from control
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GLUT transporter expression in non-polarised cells
We detected mRNA for GLUT1, GLUT2 and GLUT4 in
non-polarised H441 cells (Fig. 3a). In non-polarised cells
cultured at 10 mM glucose, a protein of predicted size for
GLUT2 (60 kDa) was detected in separated plasma
membrane and intracellular protein fractions in approxi-
mately equal quantities (Fig. 3b). A 45-kDa product
corresponding to GLUT4 protein was detected in total cell
protein and the intracellular fraction but was absent from
the plasma membrane protein fraction. It is interesting to
note that although GLUT1 mRNA was detected, translated
protein could not be detected by western blotting in these
cells (Fig. 3b). Neither GLUT3 mRNA nor protein was
detected (Fig. 3a,b).
Effect of glucose concentration on transporter expression
in non-polarised cells
GLUT2 protein was present at 1, 5, 10 and 15 mM glucose
(Figs. 3 and 4). There was an apparent increase in the
abundance of GLUT2 with increasing glucose concentra-
tion. Labelling of GLUT2 was completely inhibited by pre-
incubation of the antibody with the corresponding antigenic
peptide (Fig. 4). These changes in glucose concentration
did not induce expression of GLUT1, GLUT3 or alter the
expression of GLUT4 (data not shown).
Glucose uptake by polarised cells
Polarised cells bathed in 10 mM glucose without inhibitors
(control) took up 24.6±1.4 nmol D-glucose/mg protein and
44.0±1.2 nmol D-glucose/mg protein, respectively, across
apical and basolateral membranes (p<0.05, n=6) (Fig. 5a).
In the presence of phloretin, D-glucose uptake across both
membranes was significantly lower than control (apical 2.7±
0.1; basolateral 9.8±0.4 nmol/mg protein, p<0.001, n=6). In
the presence of phlorizin, D-glucose uptake was also
significantly lower than control across both membranes
(apical 19.6±3.6; basolateral 32.8±0.1 nmol/mg protein,
p<0.05, n=6). Ouabain had no significant effect on D-
glucose uptake across either membrane (Fig. 5a).
Fig. 3 a RT-PCR of GLUT1–GLUT4 mRNA sequences from non-
polarised H441 cells. Products were resolved on ethidium bromide-
stained agarose gels. RT-PCR products corresponding to the correct
size for GLUT1 (400 bp), GLUT2 (425 bp) and GLUT4 (299 bp)
were amplified. No products corresponding to GLUT3 (411 bp) were
detected in H441 cells but were detected in a positive control,
Ishikawa cell line (data not shown). Amplification of β-actin was used
as a control for the reaction. b Western blot analysis of glucose
transporter expression in non-polarised H441 cells. Total protein
(Total), intracellular proteins (Intracellular) and plasma membrane
protein (Plasma membrane) (50 μg) were resolved on acrylamide
gels. Immunostained products corresponding to GLUT2 (∼60 kDa)
and GLUT4 (∼45 kDa) were detected. Positive controls (+C) used:
GLUT1, skeletal muscle; GLUT2, liver; GLUT3, Ishikawa cells;
GLUT4, adipose tissue
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In the absence of inhibitors (control), uptake of AMG
across apical and basolateral membranes was 2.0±0.9 and
3.5±0.1 nmol/mg protein, respectively (n=3) (Fig. 5b). In
polarised cells, AMG uptake appeared to be slightly greater
than in non-polarised cells, but was much lower than D-
glucose or DOG uptake and was not inhibited by phlorizin
or phloretin.
DOG uptake in the absence of inhibitors (control) was
similar to D-glucose uptake (apical 36.6±1.4 nmol/mg
protein; basolateral 41.6±0.64 nmol/mg protein) (Fig. 5c).
DOG uptake across both membranes was lower than con-
trol in the presence of phloretin (apical 4.7±0.5 nmol/mg
protein; basolateral 11.36±0.65 nmol/mg protein, p<0.001,
n=3), but phlorizin had no effect. It is interesting to note
that ouabain inhibited uptake of DOG across both mem-
branes. However, taken together, these data indicate that
glucose transport via GLUTs remains the predominant route
of transport across apical and basolateral membranes when
H441 cells are polarised.
Effect of phlorizin on Isc
Apical application of phlorizin induced a small reduction in
mean Isc (∼10%) from control 55±3 to 49±3 μA cm−2 (p<
0.05, n=4). Basolateral application of phlorizin also
inhibited a small (∼10%) component of transepithelial Isc
from control, 46±5 to 42±5 μA cm−2, p<0.05, n=5. Apical
application of amiloride inhibited ∼92% of transepithelial
Isc, similar to our previous observations in these cells
(Fig. 6).
Effect of glucose concentration on glucose uptake
by polarised cells
D-Glucose uptake across the apical membrane was lowest at
1 mM glucose, 3.2±0.1 nmol/mg protein (Fig. 7a). It is
greater at 5 mM glucose, 28.9±2.3 nmol/mg protein
(Fig. 7b) (n=6, p<0.05 compared to (cf) 1 mM) and
10 mM glucose, 24.6±1.4 nmol/mg protein (Fig. 5a) (n=6,
p<0.01), but decreased at 15 mM glucose, 6.5±0.2 nmol/mg
Fig. 4 Effect of 1, 5 and
15 mM glucose on glucose
transporter protein expression in
non-polarised H441 cells. Total
protein (50 μg) was resolved on
acrylamide gels. Immunostained
products corresponding to
GLUT2 (∼60 kDa) and β-actin
(∼42 kDa) are shown. Bands
corresponding to GLUT2 were
completely inhibited by pre-
incubating the antibodies with
the antigenic peptide against
which they were raised
Fig. 5 Glucose uptake by polarised H441 cells. Effect of pre-incubation
with vehicle (C), 500 μM phlorizin (PZ), 1 mM phloretin (PT) and
1 mM ouabain (OU) on the apical or basolateral uptake of 10 mM
glucose (traced by [3H]-glucose) (a), [14C]-α-methyl-D-glucopyrano-
side (AMG) (b) or [3H]-deoxyglucose (DOG) (c). Uptake experiments
were performed at 37°C. Data are shown as mean±SEM. *p<0.05,
significantly different from control. **p<0.01, significantly different
from control. #p<0.05, significantly different from apical control
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protein (Fig. 7c) (n=6, p<0.01 cf 5 mM). A similar pattern
of D-glucose uptake was observed across the basolateral
membrane, being lowest at 1 mM (5.7±0.2 nmol/mg
protein), greater at 5 mM (48.0±2.7 nmol/mg protein (n=6,
p<0.05 cf 1 mM)) and 10 mM (43.9±1.2 nmol/mg
protein) (Fig. 5a) and decreasing at 15 mM glucose (18.1±
0.6 nmol/mg protein, n=6, p<0.05 cf 5 mM) (Fig. 7a–c).
These results indicate that H441 cells display maximal
glucose uptake under normoglycaemic conditions (5–
10 mM) but down-regulate glucose transport under con-
ditions mimicking hyperglycaemia (15 mM glucose). Phlor-
etin significantly inhibited glucose uptake at all glucose
concentrations across the apical (p<0.001, n=6) and baso-
lateral (p<0.001, n=6) membranes (Figs. 7a–c and 5a).
Effect of cell polarisation on transporter expression
GLUT2 (but not GLUT1, GLUT3 or GLUT4) proteins
were detected in the membranes of polarised cells. GLUT2
was equally distributed in the biotinylated apical and
basolateral membrane fractions but was not detected in
the intracellular non-bound protein fraction (Fig. 8a). α1-
Na+K+ATPase was predominantly located in the basolateral
biotinylated fraction and the total protein lysate but not in
the non-bound fraction consistent with its distribution in the
basolateral membrane of these cells (Fig. 8b). β-actin was
present at similar abundance in all total protein preparations
but was not detected in apical and basolateral membrane
preparations, indicating that these fractions were not
contaminated with intracellular proteins (Fig. 8a,b).
Effect of glucose concentration on transporter expression
in polarised cells
In polarised cells, basolateral abundance of GLUT2 was
apparently greater at 5 mM glucose than at 1 or 15 mM
Fig. 6 Short circuit current (Isc) measured across polarised H441 cell
monolayers before and after application of 500 μM phlorizin (PZ) or
10 μM amiloride (amiloride) to the apical compartment or 500 μM
phlorizin (PZ) or 1 mM ouabain (ouabain) to the basolateral
compartment. *p<0.05, significantly different from control. **p<
0.01, significantly different from control
Fig. 7 Effect of 1 mM (a),
5 mM (b) and 15 mM (c)
glucose on glucose uptake
(traced by [3H]-glucose) across
apical and basolateral mem-
branes in polarised H441 cells.
Cells were pre-incubated with
vehicle (C), 500 μM phlorizin
(PZ) or 1 mM phloretin (PT)
before measurement of glucose
uptake across the apical (apical)
or basolateral (basolateral)
membrane. Uptake experiments
were performed at 37°C. Data




from the apical control. †p<
0.001, significantly different
from corresponding control val-
ues for 1 and 15 mM glucose
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glucose, but we were unable to demonstrate any change in
abundance of GLUT2 in the apical membrane (Fig. 8c).
Immunocytochemistry of human bronchial mucosal biopsies
Fluorescence microscopy of three independent biopsies
from human bronchial mucosa including one control patient
with no airway disease revealed specific staining of
epithelial cells with GLUT2 antibody. Representative
sequential sections from two biopsies immunostained with
GLUT2 antiserum and counterstained with DAPI are
shown in Fig. 9. Images a–f and images g–l are from two
independent biopsies. GLUT2 immunofluorescence was
present only in the epithelial cell layer (Fig. 9a,c,g and i).
The epithelial cell membranes were clearly defined and we
could not distinguish any differences in intensity between the
apical and basolateral membranes indicating that GLUT2
was present in both (Fig. 9a,c). Non-specific binding of anti
rabbit FITC was not observed in the absence of GLUT2
antibody (Fig. 9d,f). Furthermore, we could not detect FITC
fluorescence in the epithelial cell membrane after pre-
absorption with GLUT2 antigenic peptide (Fig. 9j,l).
Discussion
The aim of our study was to characterise glucose transport
by human airway epithelial cells, using the H441 cell line
as a model. In non-polarised H441 cells, we found that D-
glucose uptake was largely inhibited by phloretin, indicat-
ing that glucose transport was predominantly via facilitated
GLUT transport. In support of this notion, the transport of
DOG (which is preferentially transported by GLUTs) was
similar to that of D-glucose and inhibited by phloretin and
cytochalasin B. We could not determine any significant
SGLT mediated glucose transport in non-polarised cells
with the use of AMG (which is preferentially transported by
SGLT), inhibition of SGLT with phlorizin, by substitution
of Na+ with choline to inhibit co-transport of Na+ with
glucose or with ouabain to inhibit activity of Na+K+ATPase
and the generation of the transmembrane Na+ gradient.
Effect of polarisation on transport
When polarised H441 cell monolayers were grown in
10 mM glucose, phloretin-sensitive transport remained the
principal mechanism of glucose uptake across the apical
and basolateral membrane. We observed that similar
amounts of glucose were transported across the basolateral
membrane to non-polarised cells but transport across the
apical membrane was significantly less. These findings are
consistent with those in cultured renal epithelial layers
where phloretin-sensitive uptake was greater across the
basolateral membrane than across the apical membrane
[33]. In contrast, DOG uptake was similar across both
membranes. We currently have no explanation for this
difference as both measurements are indicative of glucose
uptake via GLUTs [37]. However, it is possible that glucose
Fig. 8 Western blot analysis of total protein and non-bound fraction
(30 μg) or biotinylated apical and basolateral proteins isolated from
1 mg of total protein extracted from polarised H441 cells. a
Immunostained proteins corresponding to GLUT2 (∼60 kDa) were
present in the total, biotinylated apical and basolateral protein
fractions. b Immunostained proteins corresponding to the α1 subunit
of Na+K+ATPase (∼113 kDa) were present predominantly in the total
protein and basolateral fractions. a and b Immunostained products
corresponding to β-actin (∼42 kDa) were present in the total protein
and non-bound fractions. c Effect of 1, 5 and 15 mM glucose on
GLUT2 transporter abundance in biotinylated apical and basolateral
proteins from polarised H441 cells
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transporters, additional to those we have investigated, may
be present on the basolateral membrane which may have
different glucose transport characteristics and inhibitor
affinities [27]. We also found that DOG uptake in polarised
cell monolayers was inhibited by ouabain. It is interesting to
note that Na+-dependent, phloretin-sensitive uptake of DOG
has been described in human intestinal Caco-2 cells [5].
We detected a small inhibition of glucose transport
across the apical and basolateral membranes of polarised
H441 cell monolayers with phlorizin consistent with an
inhibition of SGLT transport. The appearance of phlorizin-
sensitive glucose and AMG uptake was described in renal
LLC-PK cells after polarisation [33, 35, 36]. However,
unlike the findings of Rabito et al., we found that uptake of
Fig. 9 GLUT2-fluorescent im-
munohistochemistry of repre-
sentative sequential frozen
sections from two independent
human bronchial mucosa biop-
sies (a–f) and (g–l). GLUT2–
FITC fluorescence was localized
to the epithelial cells present in
the sections (a, c, g and i). DAPI
staining of cellular nuclei was
observed in all cells visible in
the section (b, e, h and k).
Merged fluorescence images of
GLUT2–FITC and DAPI are
shown in (c, f, i and l). No FITC
fluorescence was observed in
the epithelial cells in the absence
of GLUT2 antiserum (d and f).
Pre-absorbtion of GLUT 2 anti-
serum with GLUT2 antigenic
peptide also inhibited FITC la-
belling of epithelial cells (j and
l). White arrows indicate the
position of epithelial cells. All
images were obtained at ×40
magnification. Bar=10 μm
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AMG remained low in polarised cells, was not inhibited by
phlorizin and did not tally with the phlorizin-inhibitable
proportion of D-glucose uptake. Furthermore, inhibition of
the transmembrane Na+ gradient with ouabain did not
decrease transport of D-glucose. These findings could
potentially be explained by an apical SGLT protein acting
as a glucosensor, a protein that transports Na+ but not
glucose [11, 12] but we could not obtain further evidence to
support this notion. The co-transport of glucose with Na+
via SGLT1 is electrogenic [40, 21]. Apical phlorizin
inhibited Isc consistent with apical transport of Na
+ through
SGLT. However, basolateral application of phlorizin also
inhibited Isc, which would not be consistent with a
functional role for SGLT in the basolateral membrane as it
should augment Isc. We also measured phlorizin-sensitive
Isc across cells incubated in 1 mM glucose which should
promote uptake by low capacity high affinity transporters
such as SGLT. However, as we could not determine any
difference in the effect of phlorizin on Isc at 1 or 10 mM
glucose we did not include this data. Taken together, the
inconsistencies in our data raise the possibility that
phlorizin elicited non-specific effects in our cells and that
there is no functional glucose transport via SGLT. It is
interesting to note that we were also unable to show that
glucose transport via SGLT made a detectable contribution
to electrogenic transport across human nasal epithelium in
vivo (E. Baker, personal communication). We have not yet
excluded role for SGLT1 or SGLT2 in the human airway
but further work will be required to ratify these findings.
Identity of GLUT transporters in H441 lung cells
We detected mRNA and protein for GLUT2 and GLUT4
transporter isoforms in H441 cells. Although we identified
GLUT1 mRNA in this cell line we were unable to detect
GLUT1 protein. Several studies have reported the presence
of GLUT1 mRNA in lung [2, 26]. GLUT1 protein has also
been demonstrated in resected lung lesions [29] and lung
tumours [8]. Whilst GLUT1 may be at low abundance and
beyond the limit of detection using the antiserum described
in this study, our results support the findings of Mantych et
al. who were also unable to detect GLUT1 protein in mouse
alveolar or bronchiolar epithelial cells [30]. We were unable
to detect GLUT3 mRNA or protein in H441 cells. It has
been detected in non-small cell lung carcinoma [46, 20] but
not in normal lung tissue [47].
GLUT2 protein was present in the membrane of both
H441 cells and intact human bronchial epithelium obtained
at bronchoscopy. GLUT2 protein has previously been
described in rat bronchiolar epithelium [10] and in normal
airway epithelium [19]. Thus, its presence in H441 cells
indicates that these cells could provide a useful model for
the study of airway glucose transport in vitro. We found
that GLUT2 was predominantly in the membrane of
polarised cells with very little in the intracellular compart-
ment. These findings contrast with studies in intestinal
epithelium which have indicated that there is an intracellu-
lar pool of GLUT2 that can be translocated to the
membrane in response to changes in luminal glucose
concentration [22, 23]. In polarised H441 cells and
bronchial biopsies, we detected GLUT2 expression in both
apical and basolateral membranes. This dual distribution is
consistent with models for glucose transport in intestinal
epithelium where GLUT2 has been localized to the apical
and basolateral membrane [1, 23]. The correlation of
GLUT-mediated transport and GLUT 2 protein in the
membrane of human airway cells indicate for the first time
that GLUT2 could make an important contribution to
glucose transport and homeostasis in the human airway.
We did not detect GLUT4 protein in the plasma
membrane of non-polarised or polarised H441 cells
indicating that GLUT4 does not contribute to GLUT-
mediated glucose uptake under the conditions we studied.
The distribution and function of GLUT4 in human lung
therefore remains elusive as it has been detected in human
foetal lung and in some lung carcinomas [20, 28]. Its
presence in the intracellular protein fraction from H441
cells and its potential ability to translocate to the plasma
membrane therefore merits further study. We did not look
for other GLUT isoforms in this study, although mRNA for
GLUT8 and GLUT10 have been detected in bovine and
human lung, respectively [9, 48].
Effect of glucose concentration on GLUT transport
Phloretin-sensitive glucose transport across either mem-
brane was maximal under normoglycaemic conditions
(5 mM glucose), was minimal under hypoglycaemic
conditions (1 mM glucose) and was also reduced at a high
glucose concentration mimicking hyperglycaemia (15 mM
glucose). That glucose uptake was lower in 1 mM glucose
is consistent with the transport kinetics for GLUT2 where
the rate of uptake is proportional to glucose concentration
[7, 15, 23]. However, the decrease in glucose uptake at
15 mM would indicate down-regulation of transport via
GLUT2. In the gut, GLUT2 protein abundance in the apical
membrane of the gut is dynamically regulated by luminal
glucose concentration [16, 23, 31] and GLUT2 protein
levels were reduced in human foetal hepatocytes by
hyperglycaemic conditions [49]. We were unable to
demonstrate any obvious changes in GLUT2 protein
abundance in the membranes of our cells which would
underlie such changes. This could reflect the lack of
sensitivity of our assay or could indicate that there are
other GLUT transporters contributing to phloretin-sensitive
uptake in lung cells. Our data indicate that this is unlikely
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to be GLUT1, GLUT3 or GLUT4 but more work will be
necessary to fully exclude these transporters.
In summary, our data shows that glucose transport across
the apical and basolateral membranes of polarised H441
airway epithelial cells utilises GLUT2 transporters. Fur-
thermore, glucose concentration modulated transport
through GLUTs. Whilst, we fully recognise that H441 cells
are a cancer cell line and may not fully represent glucose
transport across airway epithelial cells in vivo, GLUT2 was
present also in the epithelial cells of human bronchial
mucosa biopsies. Our study provides the first evidence that
regulation of glucose transport in human airway could
involve GLUT2. The specific role of these transporters in
regulating glucose homeostasis across human airway
epithelium in health and disease now requires further study.
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